PyInvesting

Market research

688266.SHG Suzhou Zelgen Biopharmaceuticals Co., Ltd

SHG CNY Healthcare

Latest close

73.89 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
24B
P/E ratio
42.43
Analyst target
180.69
Dividend yield
Not available
Beta
-0.11

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Suzhou Zelgen Biopharmaceuticals Co., Ltd is currently in a long term downtrend where the price is trading 9.4% below its 200 day moving average.

From a valuation standpoint, the stock is 4854.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 477.2.

Based on the above factors, Suzhou Zelgen Biopharmaceuticals Co., Ltd gets an overall score of 0/5.